A Study to Evaluate the Efficacy and Safety of Bismuth-Containing Quadruple Therapy With Oral Vonoprazan (TAK-438) 20 mg Compared to Esomeprazole 20 mg Twice Daily in Paticipants With Helicobacter Pylori Infection

Condition:   Helicobacter Pylori Interventions:   Drug: Vonoprazan;   Drug: Amoxicillin;   Drug: Clarithromycin;   Drug: Bismuth Potassium citrate;   Drug: Esomeprazole Sponsor:   Takeda Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials